Michael Newnham

2.8k total citations · 1 hit paper
25 papers, 443 citations indexed

About

Michael Newnham is a scholar working on Pulmonary and Respiratory Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Michael Newnham has authored 25 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 7 papers in Internal Medicine and 5 papers in Surgery. Recurrent topics in Michael Newnham's work include Pulmonary Hypertension Research and Treatments (8 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers) and Venous Thromboembolism Diagnosis and Management (7 papers). Michael Newnham is often cited by papers focused on Pulmonary Hypertension Research and Treatments (8 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers) and Venous Thromboembolism Diagnosis and Management (7 papers). Michael Newnham collaborates with scholars based in United Kingdom, Jamaica and United States. Michael Newnham's co-authors include Daniella A. Spittle, Alice Turner, Joanna Pepke‐Żaba, David P. Jenkins, Choo Ng, John Cannon, Dolores Taboada, Mark Toshner, Katherine Bunclark and Steven Tsui and has published in prestigious journals such as Scientific Reports, CHEST Journal and European Respiratory Journal.

In The Last Decade

Michael Newnham

21 papers receiving 426 citations

Hit Papers

COVID-19, immunothrombosis and venous thromboembolism: bi... 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Newnham United Kingdom 9 204 142 117 111 70 25 443
Hooman Poor United States 9 165 0.8× 146 1.0× 87 0.7× 95 0.9× 67 1.0× 18 405
Stephen MacDonald United Kingdom 12 55 0.3× 151 1.1× 194 1.7× 129 1.2× 76 1.1× 22 558
Louise Bowles United Kingdom 12 92 0.5× 293 2.1× 123 1.1× 91 0.8× 154 2.2× 18 804
Barry Kevane Ireland 15 80 0.4× 130 0.9× 220 1.9× 138 1.2× 44 0.6× 56 614
Luca Luzzani Italy 11 188 0.9× 207 1.5× 89 0.8× 71 0.6× 184 2.6× 24 496
J D Nielsen Denmark 8 60 0.3× 55 0.4× 133 1.1× 63 0.6× 61 0.9× 9 427
Nadin Elsayed United States 9 259 1.3× 294 2.1× 133 1.1× 183 1.6× 191 2.7× 42 652
Sahar Memar Montazerin United States 11 46 0.2× 116 0.8× 55 0.5× 70 0.6× 49 0.7× 26 322
Luciana Tamie Kato Morinaga Brazil 12 282 1.4× 50 0.4× 180 1.5× 235 2.1× 25 0.4× 22 585
Mateo Porres‐Aguilar United States 13 167 0.8× 38 0.3× 150 1.3× 142 1.3× 32 0.5× 64 469

Countries citing papers authored by Michael Newnham

Since Specialization
Citations

This map shows the geographic impact of Michael Newnham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Newnham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Newnham more than expected).

Fields of papers citing papers by Michael Newnham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Newnham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Newnham. The network helps show where Michael Newnham may publish in the future.

Co-authorship network of co-authors of Michael Newnham

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Newnham. A scholar is included among the top collaborators of Michael Newnham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Newnham. Michael Newnham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Aunger, Justin Avery, et al.. (2025). Interventions to Improve Adherence to Clinical Guidelines for the Management and Follow-Up of Pulmonary Nodules. CHEST Journal. 168(1). 248–268. 1 indexed citations
4.
Ignatowicz, Agnieszka, Sheila Greenfield, Clare Prince, et al.. (2025). Interventions that challenge established and accepted clinical practice: lessons learnt from a process evaluation of the STOP-APE trial. Health Technology Assessment. 29(11). 1–11.
5.
Lasserson, Daniel, Samir Mehta, Agnieszka Ignatowicz, et al.. (2024). Stopping anticoagulation for isolated or incidental pulmonary embolism: the STOPAPE RCT protocol. Health Technology Assessment. 29(11). 1–17. 2 indexed citations
6.
Ellis, Paul, et al.. (2024). Bronchiectasis Occurs Independently of Chronic Obstructive Pulmonary Disease in Alpha-1 Antitrypsin Deficiency. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 11(5). 507–514. 1 indexed citations
7.
Ellis, Paul, Emily J Bailey, Radmila Choate, et al.. (2024). Prevalence of Cardiovascular Disease and Rate of Major Adverse Cardiovascular Events in Severe Alpha-1 Antitrypsin Deficiency COPD. International Journal of COPD. Volume 19. 149–159. 1 indexed citations
8.
Liley, James, Katherine Bunclark, Michael Newnham, et al.. (2024). Development of an open-source tool for risk assessment in pulmonary endarterectomy. European Respiratory Journal. 65(3). 2401001–2401001.
9.
Spittle, Daniella A., et al.. (2023). Predicting Lung Function Using Biomarkers in Alpha-1 Antitrypsin Deficiency. Biomedicines. 11(7). 2001–2001. 5 indexed citations
10.
Newnham, Michael, Mark Quinn, & Alice Turner. (2023). Estimating the Prevalence of AATD Patients in the UK to Identify Underdiagnosis and Determine the Eligibility for Potential Augmentation Therapy. International Journal of COPD. Volume 18. 1197–1205. 2 indexed citations
11.
Turner, Alice, et al.. (2022). Cardiovascular disease in chronic obstructive pulmonary disease: a narrative review. Thorax. 77(9). 939–945. 42 indexed citations
12.
Lasserson, Daniel, et al.. (2022). A multicentre observational study of the prevalence, management, and outcomes of subsegmental pulmonary embolism. Journal of Thrombosis and Thrombolysis. 55(1). 126–133. 5 indexed citations
13.
Hadinnapola, Charaka, Mark Southwood, Jules Hernández‐Sánchez, et al.. (2022). Angiopoietin 2 and hsCRP are associated with pulmonary hemodynamics and long-term mortality respectively in CTEPH—Results from a prospective discovery and validation biomarker study. The Journal of Heart and Lung Transplantation. 42(3). 398–405. 9 indexed citations
14.
Spittle, Daniella A., et al.. (2021). COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms. Thorax. 76(4). 412–420. 204 indexed citations breakdown →
15.
Newnham, Michael, Katherine Bunclark, John Cannon, et al.. (2020). CAMPHOR score: patient-reported outcomes are improved by pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension. European Respiratory Journal. 56(4). 1902096–1902096. 34 indexed citations
16.
Bunclark, Katherine, Michael Newnham, Yi‐Da Chiu, et al.. (2019). A multicenter study of anticoagulation in operable chronic thromboembolic pulmonary hypertension. Journal of Thrombosis and Haemostasis. 18(1). 114–122. 71 indexed citations
17.
Newnham, Michael & Alice Turner. (2019). Diagnosis and treatment of subsegmental pulmonary embolism. 9(3). 30–34. 5 indexed citations
18.
Newnham, Michael, et al.. (2012). Management of Breast Abscesses in Jamaican Women: Is There Need for a Paradigm Shift?. West Indian Medical Journal. 61(3). 245–248. 3 indexed citations
19.
Cawich, Shamir O, et al.. (2007). Emergency department thoracotomy in Jamaica: A case controlled study. International Journal of Surgery. 5(5). 311–315. 11 indexed citations
20.
Newnham, Michael, et al.. (2006). A comparison of open and laparoscopic cholecystectomy done by a surgeon in training. West Indian Medical Journal. 55(2). 103–9. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026